John Maskill, 89, decided to walk the Cinder Track after losing his wife to Progressive Supranuclear Palsy (PSP) in March.

Troculeucel, a cryopreserved, autologous enhanced natural killer cell therapy, has demonstrated preliminary clinical benefit without any drug-related adverse events in two Phase I clinical trials in ...